Immediate Impact
7 hit
Citing Papers
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
2023 Hit
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
2023 Hit
Works of Tong Luo being referenced
Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer
2020
Abstract 4756: In vivo efficacy of combined targeting of CDK4/6, ER and PI3K signaling in ER+ breast cancer
2014